Li Andraia R, Valdebran Manuel, Reuben Daniel Y
Department of Dermatology and Dermatologic Surgery, Medical University of South Carolina, Charleston, SC, United States.
Department of Pediatrics, Medical University of South Carolina, Charleston, SC, United States.
Front Med (Lausanne). 2021 Nov 8;8:769368. doi: 10.3389/fmed.2021.769368. eCollection 2021.
In March 2020, the designation of the COVID-19 outbreak as a worldwide pandemic marked the beginning of an unprecedented era in modern medicine. Facing the possibility of resource precincts and healthcare rationing, leading dermatological and cancer societies acted expeditiously to adapt their guidelines to these contingencies. Melanoma is a lethal and aggressive skin cancer necessitating a multidisciplinary approach to management and is associated with significant healthcare and economic cost in later stages of disease. In revisiting how the pandemic transformed guidelines from diagnosis and surveillance to surgical and systemic management of melanoma, we appraise the evidence behind these decisions and their enduring implications.
2020年3月，新型冠状病毒肺炎疫情被认定为全球大流行，标志着现代医学进入了一个前所未有的时代。面对资源短缺和医疗资源分配的可能性，领先的皮肤病学和癌症学会迅速采取行动，调整其指南以应对这些突发情况。黑色素瘤是一种致命且侵袭性强的皮肤癌，需要多学科方法进行管理，并且在疾病后期会带来巨大的医疗和经济成本。在重新审视疫情如何改变黑色素瘤从诊断、监测到手术及全身管理的指南时，我们评估了这些决策背后的证据及其持久影响。
